Risk factors for<unk>  depend on several different characteristics of the patient, the type of cancer, and the type of chemotherapy used.<unk>  Characteristics:<unk> s with a high cell turnover rate, rapid growth rate, and high<unk>  bulk tend to be more associated with the development of<unk> . The most common<unk> s associated with this<unk>  are poorly differentiated lymphomas (such as Burkitt's lymphoma), other Non-Hodgkin Lymphomas (NHL), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML). Other cancers (such as melanoma) have also been associated with<unk>  but are less common. Patient Characteristics: Certain patient-related factors can affect the development of clinical<unk> . These factors include elevated baseline serum creatinine, kidney failure, dehydration, and other issues affecting urinary flow or the acidity of urine. Chemotherapy Characteristics: Chemo-sensitive<unk> s, such as lymphomas, carry a higher risk for the development of<unk> . Those<unk> s that are more responsive to a chemotherapy agent carry a higher<unk>  risk. Usually, the precipitating medication regimen includes combination chemotherapy, but<unk>  can be triggered in cancer patients by steroid treatment alone, and sometimes without any treatment—in this case the condition is referred to as "spontaneous<unk> ".
Tumor lysis syndrome
Distributive shock
Sepsis
Multiple organ dysfunction syndrome
Cryptic shock
Septic shock
Vasodilatory shock
Hypovolemic shock